checkAd
    Polynovo Aktie
    1,2400
     
    EUR
    0,00 %
    0,0000 EUR
    Letzter Kurs 02.05.24 Lang & Schwarz
    1,2200
     
    EUR
    367 STK
    Geldkurs 02.05.24
    1,2600
     
    EUR
    367 STK
    Briefkurs 02.05.24
    ISIN: AU000000PNV0 · WKN: A12F4T · Australien

    Polynovo Bilanz & GuV

    GuV in Mio AUD

    20192020202120222023
    Umsatz14,0422,1629,1641,4465,24
    Bruttoergebnis vom Umsatz9,505,017,8316,2319,33
    EBITDA-2,83-3,30-3,111,54-3,90
    EBIT-3,52-4,14-4,23-0,26-6,19
    Ergebnis vor Steuer-3,19-4,16-4,55-1,15-4,93
    Ergebnis nach Steuern-3,19-4,19-4,61-1,19-4,92

    Bilanz in Mio AUD

    20192020202120222023
    Aktiva28,2337,8638,3434,9792,62
    Umlaufvermögen19,9019,2816,1016,0467,35
    Summe Anlagevermögen8,1618,5822,2418,9325,27
    Passiva28,2337,8638,3434,9792,62
    Summe kurzfristige Verbindlichkeiten2,069,478,657,7612,67
    Summe langfristige Verbindlichkeiten0,074,577,349,5014,57
    Summe Fremdkapital2,1314,0415,9917,2627,24
    Bilanzielles Eigenkapital26,1023,8122,3517,7265,38

    Cashflow in AUD

    20192020202120222023
    Cashflow-3,37 Mio.-402,56 Tsd.-248,74 Tsd.-2,06 Mio.-5,93 Mio.
    Kennzahlen und Daten von

    Polynovo Unternehmensprofil

    Polynovo Insidertrades 2024

    Zeitraum 

      Kennzahlen in AUD

      201920202021202220232024e
      Kurs-Gewinn-Verhältnis (KGV)-314,04-275,85-266-726,80-203,40208,42
      Kurs-Cash-Flow-Verhältnis (KCV)-157,02-2.758,50-6.650-484,53-203,40
      Kurs-Buchwert-Verhältnis (KBV)39,2668,9688,6748,4522,60
      Kurs-Umsatz-Verhältnis (KUV)78,5191,9566,5024,2322,60
      Umsatz je Aktie0,020,030,040,060,09
      Cashflow je Aktie-0,010,000,000,00-0,01
      Anlageintensität29,00 %49,00 %58,00 %54,00 %27,00 %
      Arbeitsintensität71,00 %51,00 %42,00 %46,00 %73,00 %
      Eigenkapitalquote92,46 %62,90 %58,30 %50,66 %70,59 %
      Fremdkapitalquote7,54 %37,10 %41,70 %49,34 %29,41 %
      Verschuldungsgrad8,16 %58,98 %71,52 %97,41 %41,66 %
      Working Capital in Mio.17,849,807,598,4354,69
      Deckungsgrad A319,99 %128,17 %100,50 %93,59 %258,77 %
      Deckungsgrad B319,99 %138,84 %123,24 %108,40 %265,85 %
      Deckungsgrad C278,49 %130,31 %113,26 %95,59 %225,43 %

      Aktieninformationen in AUD

      20192020202120222023
      Aktien im Umlauf in Mio.661,09661,09663,35664,27698,68

      Mitarbeiter

      2024e
      Anzahl Mitarbeiter237


      Aktionärsstruktur

      Profil

      PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

      Kennzahlen und Daten von

      Polynovo Kontakt

      AdressePutnam Investment Funds
      Telefon61 3 8681 4050
      Internethttps://polynovo.com

      Super Micro Computer verfünffacht Gewinn, Aktie nach Zahlen volatil